Opendata, web and dolomites

TRANSVAC2 SIGNED

European Vaccine Research and Development Infrastructure

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "TRANSVAC2" data sheet

The following table provides information about the project.

Coordinator
EUROPEAN VACCINE INITIATIVE EWIV 

Organization address
address: VOSSSTRASSE 2 GEB 4040
city: HEIDELBERG
postcode: 69115
website: http://www.euvaccine.eu/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.transvac.org/
 Total cost 10˙599˙993 €
 EC max contribution 10˙599˙993 € (100%)
 Programme 1. H2020-EU.1.4.1.2. (Integrating and opening existing national and regional  research infrastructures of European interest)
 Code Call H2020-INFRAIA-2016-1
 Funding Scheme RIA
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2022-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EUROPEAN VACCINE INITIATIVE EWIV DE (HEIDELBERG) coordinator 1˙254˙147.00
2    UNIVERSITA DEGLI STUDI DI SIENA IT (SIENA) participant 706˙430.00
3    VACCINE FORMULATION INSTITUTE LIMITED UK (GODALMING) participant 670˙975.00
4    COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES FR (PARIS 15) participant 669˙527.00
5    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 640˙594.00
6    STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER NL (RIJSWIJK ZH) participant 626˙813.00
7    STATENS SERUM INSTITUT DK (KOBENHAVN S) participant 601˙445.00
8    INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA PT (OEIRAS) participant 595˙332.00
9    INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES ES (CALDES DE MONTBUI BARCELONA) participant 587˙866.00
10    ACADEMISCH ZIEKENHUIS LEIDEN NL (LEIDEN) participant 555˙000.00
11    FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. DE (MUNCHEN) participant 490˙307.00
12    STICHTING WAGENINGEN RESEARCH NL (WAGENINGEN) participant 471˙015.00
13    HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH DE (BRAUNSCHWEIG) participant 402˙090.00
14    Department of Health UK (Leeds) participant 384˙120.00
15    MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT NL (DEN HAAG) participant 334˙975.00
16    EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH CH (ZUERICH) participant 288˙000.00
17    ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK FR (PARIS) participant 226˙750.00
18    UNIVERSITEIT LEIDEN NL (LEIDEN) participant 212˙050.00
19    EATRIS ERIC NL (AMSTERDAM) participant 211˙831.00
20    INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT FR (PARIS CEDEX 07) participant 202˙283.00
21    LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER UK (LONDON) participant 130˙832.00
22    BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE FR (LYON) participant 124˙031.00
23    GENIBET - BIOPHARMACEUTICALS SA PT (OEIRAS) participant 108˙992.00
24    SCLAVO VACCINES ASSOCIATION IT (SIENA) participant 75˙320.00
25    INSTRUCT ACADEMIC SERVICES LIMITED UK (OXFORD) participant 29˙260.00
26    UNIVERSITE DE LAUSANNE CH (LAUSANNE) participant 0.00

Map

 Project objective

TRANSVAC2 is the follow-up project to its successful predecessor project TRANSVAC, the European Network of Vaccine Research and Development funded under FP7. The TRANSVAC2 consortium comprises a comprehensive collection of leading European institutions that propose to further advance with the previous initiative towards the establishment of a fully operational and sustainable European vaccine R&D infrastructure. TRANSVAC2 will support innovation for both prophylactic and therapeutic vaccine development based on a disease-overarching and one-health approach, thereby optimising the knowledge and expertise gained during the development of both human and animal vaccines. This will be achieved by bridging the translational gap in biomedical research, and by supporting cooperation between public vaccine R&D institutions of excellence, related initiatives and networks in Europe, and industrial partners. TRANSVAC2 will complement and integrate with existing European research infrastructures in both the public and private sectors. TRANSVAC2 will function as leverage and innovation catalyst between all stakeholders involved in vaccine R&D in Europe and -by providing integrated and overarching vaccine R&D services- will contribute to the development of effective products to address European and global health challenges, to controlling the burden and spread of infectious diseases, and reinforce the economic assets represented by vaccine developers in Europe. The impact of TRANSVAC2 will be maximised by two external advisory bodies. An independent Scientific & Ethics Advisory Committee will provide recommendations surrounding scientific-technical and ethical issues, whereas the coordination of TRANSVAC2 with other related initiatives and the further promotion of the long-term stability of a European vaccine R&D infrastructure will be supported by a Board of Stakeholders comprising representatives of policy and decision makers, industry associations and European infrastructures.

 Deliverables

List of deliverables.
Standardised assays for the characterisation of immune sera by calibration-free concentration analysis Other 2020-02-25 15:31:00
Programme for customised training courses Other 2020-02-25 15:31:00
Launch of TRANSVAC2 web site Websites, patent fillings, videos etc. 2020-02-25 15:31:01
Contact with five external projects and initiatives Other 2020-02-25 15:31:00
Detailed description of the infrastructure for the TRANSVAC2 web site Documents, reports 2020-02-25 15:31:01
Standardised assays for the functional characterisation of vaccine candidates using monoclonal antibodies and/or ligand interactions Other 2020-02-25 15:31:00
Establishment of Board of Stakeholders Other 2020-02-25 15:31:01
Appointment of all SEAC members Other 2020-02-25 15:31:01

Take a look to the deliverables list in detail:  detailed list of TRANSVAC2 deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRANSVAC2" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TRANSVAC2" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.4.1.2.)

AQUACOSM-plus (2020)

Network of Leading Ecosystem Scale Experimental AQUAtic MesoCOSM Facilities Connecting Rivers, Lakes, Estuaries and Oceans in Europe and beyond

Read More  

SFERA-III (2019)

Solar Facilities for the European Research Area - Third Phase

Read More  

ESTEEM3 (2019)

Enabling Science and Technology through European Electron Microscopy

Read More